Synergistic Vascular Disease Diagnosis and Treatment System

A comprehensive system integrating AI, IoT, blockchain, and 3D printing technologies to diagnose and treat vascular diseases more accurately and efficiently.

The original patent disclosed a method for diagnosing vascular disease using geometric feature parameter learning data and fractional flow reserve data. However, the limitations of this approach lie in its inability to incorporate diverse data sources, ensure data security, and provide personalized treatment recommendations. The new inventive concept addresses these limitations by combining AI-powered analysis, IoT-based wearable devices, blockchain-based secure data storage, and 3D printing technology to create a more powerful and effective system for vascular disease diagnosis and treatment.

The synergistic system comprises multiple components: a blockchain-based decentralized data storage unit for storing medical records and diagnosis results; an AI-powered analysis module for analyzing the stored data and generating a diagnosis report; an IoT-based wearable device for detecting early signs of vascular disease; a 3D printing module for creating personalized models of vascular structures for further analysis; and a hybrid AI-IoT system for real-time monitoring of cardiovascular health. The system integrates these components to provide a comprehensive diagnosis and personalized treatment recommendations, ensuring more accurate and efficient diagnosis and treatment of vascular diseases.

The new inventive concept's novelty lies in its synergistic combination of distinct technologies, including AI, IoT, blockchain, and 3D printing, to create a more powerful and effective system for vascular disease diagnosis and treatment. The inventive step is the integration of these technologies to provide a comprehensive and personalized approach to vascular disease diagnosis and treatment, which is not obvious from the original patent.

Alternative embodiments of the inventive concept could include using different AI algorithms, incorporating additional data sources such as electronic health records, or utilizing alternative 3D printing materials. Variations could include adapting the system for diagnosing other diseases or using the system in conjunction with other medical devices.

The synergistic vascular disease diagnosis and treatment system has significant commercial potential in the healthcare industry, particularly in the areas of cardiovascular disease diagnosis and treatment. The system's ability to provide accurate and personalized diagnosis and treatment recommendations makes it an attractive solution for healthcare providers and patients alike.